BREAKING: FDA authorizes Eli Lilly's Covid-19 antibody treatment for emergency use

To ensure delivery to your inbox add email@mail.nbcnews.com to your contacts | View in browser Add NBC News to your contacts Unsubscribe from this email

Nov 09, 2020 BREAKING: FDA authorizes Eli Lilly's Covid-19 antibody treatment for emergency use The Food and Drug Administration has granted an emergency use authorization for Eli Lilly's Covid-19 monoclonal antibody treatment, called bamlanivimab. The FDA has stipulated that the emergency use authorization does not apply to patients who are in the hospital or who need help breathing. Read More Get the NBC News Mobile App Follow NBC News Check out all of NBCNEWS Newsletters here. Update Preferences | Unsubscribe | Contact | Privacy Update Preferences Unsubscribe Contact Privacy